NCCN Guidelines Insights: Prostate Cancer, Version 1.2023
Posted: 01/23/2023 | By: Melissa E. Fryman, MS

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. Test your knowledge on the NCCN Guidelines Insights, which summarize the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.

Question 1 of 5

All of the following are strongly recommended for most patients with metastatic castration-sensitive prostate cancer, except for:

Choose 1